RE: fsd pharma is legit! Go check them outThrough the acquisition of Prismic Pharmaceuticals in June 2019, FSD Pharma attained the worldwide rights (except for Italy and Spain) of the micronized and ultra-micronized formulations of palmitoylethanolamide (micro-PEA and ultra-micronized-PEA). Prismic had previously acquired the license to conduct R&D and commercialize micronized-PEA and ultra-micronized-PEA as a prescription medication for the relief of inflammation and pain from Epitech Group SpA. Today, Prismic Pharmaceuticals is the core of the FSD Pharma Bioscience Division.